Why Choose BioSRQ?
When you partner with BioSRQ, you have access to a team of more than 60 scientists and clinicians who have expertise in a wide range of disciplines from around the world.
We work hard to advance your drug therapies efficiently and cost effectively.
We have been working with non-profit and for-profit entities for over 10 years to utilize our expertise. BioSRQ has excelled in meeting and exceeding client needs in clinical and pre-clinical settings.
Who We Are
The executive leadership of BioSRQ each have more than 20 years of science, research, and/or business experience.
Michael Mullan, M.D,PH.D
Chief Executive Officer
Dr. Mullan earned his medical degree from The Royal Free Hospital Medical School, University of London and his Ph.D. in the molecular genetics of Alzheimer’s Disease from St. Mary’s Hospital Medical School, University of London. Dr. Mullan has previously served as CEO or CSO of both publicly traded and private drug development companies including The Roskamp Institute which he co-founded in 2003.
Fiona Crawford, Ph.D
Chief Operating Officer
Dr. Crawford is from Belfast, Northern Ireland, and her Ph.D. training was in London, England, where she was a part of the team that identified the first Alzheimer’s mutations. Dr. Crawford has over 30 years of experience in the field of research and development for Alzheimer’s disease and related disorders. Throughout her career, Dr. Crawford has received and managed numerous grants and contracts for neuroscience research.
Chief Financial Officer
Mr. Dodd received an undergraduate degree in Accounting from Virginia Tech and an MBA from Virginia Commonwealth University. His experience includes financial reporting, budgeting and forecasting, management reporting, and financial planning. Mr. Dodd has over 30 years of financial experience with Consumer Products, Bio-tech and Manufacturing companies.
Corbin Bachmeier, Ph.D
Director of Pharmaceutical Sciences
Dr. Bachmeier received a Bachelor of Science degree in Biology from the University of North Dakota and a doctoral degree in Pharmaceutical Sciences from the University of Nebreaska Medical Center.
Administrative Project Manager
Mr. Dreger has a Bachelors in Biomedical Sciences from the University of Central Florida. While at UCF, he was a LEAD Scholar which taught him several effective ways of leading a diverse and knowledgeable group.
Chao Jin, Ph.D
Director of Chemistry
Dr. Jin received a Bachelor of Science degree in General Chemistry from Nankai University and a Master of Science degree in Analytical Chemistry from Institute of Chemistry, Beijing. He earned a doctoral degree in Organic Chemistry from the University at Albany, State University of New York. Dr. Jin has over 25 years of experience in chemical synthesis in the field of drug discovery.
Tural Akhmedov, Ph.D
Dr. Akhmedov received his Bachelor’s of Science degree in chemistry from West Virginia University. He earned his doctorate degree at the University of Florida.
Hailan Yao, Ph.D
Lead Gentetic Engineer
Dr. Yao received a doctorate degree from the Institute of Neuroscience, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences (CAS).
In addition to our in-house team above, we have access to a wide range of experts including members below: